我国新药现状和分析  

An Analysis of the Current Status of New Drugs in China

作　　者：孔英梅[1] 

机构地区：[1]卫生部药品审评办公室,100050

出　　处：《中国药事》1992年第1期41-43,共3页Chinese Pharmaceutical Affairs

摘　　要：本文总结了我国自《药品管理法》实施后五年多来在新药审评工作上取得的成绩,并分析了尚存在的问题和对今后加速审评速度的改进建议.This paper summarized the achievements in the new drug evaluation during the five years after the Drug Administation Law coming into effect, analyzed the current problems and offered proposals for improving new drug evaluation.

关 键 词：新药审批 现状 分析 

分 类 号：R97[医药卫生—药品]